このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Shanghai Haohai Biological Technology バランスシートの健全性
財務の健全性 基準チェック /56
Shanghai Haohai Biological Technologyの総株主資本はCN¥6.1B 、総負債はCN¥390.2Mで、負債比率は6.4%となります。総資産と総負債はそれぞれCN¥7.2BとCN¥1.1Bです。 Shanghai Haohai Biological Technologyの EBIT はCN¥407.0Mで、利息カバレッジ比率-6です。現金および短期投資はCN¥2.7Bです。
主要情報
6.3%
負債資本比率
CN¥380.74m
負債
| インタレスト・カバレッジ・レシオ | -6.5x |
| 現金 | CN¥2.74b |
| エクイティ | CN¥6.06b |
| 負債合計 | CN¥1.19b |
| 総資産 | CN¥7.24b |
財務の健全性に関する最新情報
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25
Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Recent updates
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All
May 22Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16Can Mixed Fundamentals Have A Negative Impact on Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Current Share Price Momentum?
Feb 23財務状況分析
短期負債: 6826の 短期資産 ( CN¥3.7B ) が 短期負債 ( CN¥689.8M ) を超えています。
長期負債: 6826の短期資産 ( CN¥3.7B ) が 長期負債 ( CN¥381.0M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: 6826総負債よりも多くの現金を保有しています。
負債の削減: 6826の負債対資本比率は、過去 5 年間で1%から6.4%に増加しました。
債務返済能力: 6826の負債は 営業キャッシュフロー によって 十分にカバー されています ( 161.6% )。
インタレストカバレッジ: 6826支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。